[PLX] YoY Quarter Result on 30-Sep-2011 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 35.17%
YoY- -258.73%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 3,707 3,359 5,390 1,132 3,184 0 0 -
PBT -8,010 -5,747 -5,479 0 0 0 0 -
Tax 49 0 -81 108 -374 -152 -222 -
NP -8,010 -5,747 -5,479 -8,875 -2,474 -5,894 -6,496 3.55%
Tax Rate - - - - - - - -
Total Cost 11,717 9,106 10,869 10,007 5,658 5,894 6,496 10.32%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin -216.08 -171.09 -101.65 -784.01 -77.70 0.00 0.00 -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
EPS -0.09 -0.06 -0.06 -0.10 -0.03 -0.08 -0.09 0.00%
EPS Diluted -0.09 -0.06 -0.06 -0.10 -0.03 -0.08 -0.09 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.